Free Newsletter
ED drugs slapped with new warning
Here's a trade-off that could have been dreamed up by a Puritan: Treat your ED, go deaf. The FDA is adding new warnings of sudden hearing loss to three of the popular ED drugs--you know their names. The agency doesn't have proof that the drugs caused sudden deafness but decided to add the warning after digging up 29 reports of the problem since 1996. The scary part, agency officials said, was that these patients lost their hearing--in one ear only--within two days of starting on the meds, sometimes within hours. In a third of the cases, the loss was temporary.
- read the FDA warning
- check out the report from the Associated Press
Related Articles:
Gene therapy approach may work against ED. Report
Safety concerns force delay for Phase III ED trial. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: